Boston Scientific Receives Approval on New Stent

New England Council member Boston Scientific recently received Food and Drug Administration approval of their new Innova Vascular Self-Expanding Stent System.

The stent will be used as a treatment for patients with narrowing or blockages in the superficial femoral artery or proximal popliteal artery. Without treatment, the narrowing or blockages in those arteries can lead to peripheral artery disease which affects more than 200 million people worldwide and can lead to painful ulcers, infections, or amputation of the toes or feet. Boston Scientific has begun a full commercial launch of the Innova Stent System.

President of Peripheral Interventions at Boston Scientific Jeff Mirviss said, “This is an important therapy for a disease that can have life-changing consequences, including limb amputation. The Innova and the Eluvia Stent Systems together demonstrate our commitment to improving health outcomes in the treatment of a disease affecting more than 200 million people worldwide.”

The New England Council congratulates Boston Scientific on the approval of their new stent.

For more information, see this Worcester Business Journal article or the Boston Scientific press release.

img_side
mask_sidebar
Recently from the Blog

November 24 Weekly Round-Up: NEC Members Contribute to COVID-19 Crisis Response

11/24/2020 | Read Post

MassDevelopment Issues Bond for New Perkins School Building and Dorm

11/19/2020 | Read Post

In the News

NEC Elects Six Respected Regional Business Leaders to Board of Directors

09/28/2020 | Read Press Release

NEC Announces 2020 New Englanders of the Year

08/25/2020 | Read Press Release